Date of Presentation
5-2-2024 12:00 AM
College
Rowan-Virtua School of Osteopathic Medicine
Poster Abstract
Esketamine has emerged as a promising treatment option, particularly noted for its effectiveness in reducing postpartum depression, alleviating pain, and promoting faster recovery. Despite its therapeutic benefits, recent research has raised concerns regarding potential adverse effects associated with high doses of esketamine in patients. Specifically, there is growing interest in understanding the potential risks linked to the administration of esketamine during cesarean delivery, given its increasing use in obstetric anesthesia.
This comprehensive review aims to investigate the potential associations between the use of esketamine during cesarean delivery and the subsequent risk of related diseases or physiological disorders. The goal is to provide clinicians and researchers with valuable insights into the safety profile of esketamine when administered during cesarean delivery, thereby informing clinical practice and guiding future research directions.
Keywords
Esketamine, Cesarean Section, Analgesics, Pain Management, Postpartum Depression, Drug-Related Side Effects and Adverse Reactions, Risk Factors, Obstetric Surgical Procedures, Anesthesia
Disciplines
Anesthesia and Analgesia | Anesthesiology | Health and Medical Administration | Investigative Techniques | Medicine and Health Sciences | Obstetrics and Gynecology | Patient Safety | Physiological Processes | Surgical Procedures, Operative | Women's Health
Document Type
Poster
DOI
10.31986/issn.2689-0690_rdw.stratford_research_day.111_2024
YouTube Video Link
Included in
Anesthesia and Analgesia Commons, Anesthesiology Commons, Health and Medical Administration Commons, Investigative Techniques Commons, Obstetrics and Gynecology Commons, Patient Safety Commons, Physiological Processes Commons, Surgical Procedures, Operative Commons, Women's Health Commons
Does Esketamine in Cesarean Delivery Increase Postoperative Adversities and Related Diseases?
Esketamine has emerged as a promising treatment option, particularly noted for its effectiveness in reducing postpartum depression, alleviating pain, and promoting faster recovery. Despite its therapeutic benefits, recent research has raised concerns regarding potential adverse effects associated with high doses of esketamine in patients. Specifically, there is growing interest in understanding the potential risks linked to the administration of esketamine during cesarean delivery, given its increasing use in obstetric anesthesia.
This comprehensive review aims to investigate the potential associations between the use of esketamine during cesarean delivery and the subsequent risk of related diseases or physiological disorders. The goal is to provide clinicians and researchers with valuable insights into the safety profile of esketamine when administered during cesarean delivery, thereby informing clinical practice and guiding future research directions.